All-	all-	O	O	O	O
trans-retinoic	trans-retinoic	O	O	O	O
acid-induced	acid-induced	O	O	O	O
erythema	erythema	O	DISEASE	OTHERS	I
nodosum	nodosum	O	DISEASE	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
acute	acute	O	O	OTHERS	I
promyelocytic	promyelocytic	O	O	OTHERS	I
leukemia	leukemia	O	O	OTHERS	I
.	.	O	O	O	O

Erythema	erythema	O	DISEASE	OTHERS	I
nodosum	nodosum	O	DISEASE	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
all-	all-	O	O	O	O
trans-retinoic	trans-retinoic	O	O	O	O
acid	acid	O	O	O	O
(	(	O	O	O	O
ATRA	atra	O	O	OTHERS	I
)	)	O	O	O	O
for	for	O	O	O	O
acute	acute	O	O	OTHERS	I
promyelocytic	promyelocytic	O	O	OTHERS	I
leukemia	leukemia	O	O	OTHERS	I
(	(	O	O	O	O
APL	apl	O	O	OTHERS	I
)	)	O	O	O	O
is	is	O	O	O	O
very	very	O	O	O	O
rare	rare	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
describe	describe	O	O	O	O
four	four	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
classic	classic	O	O	O	O
APL	apl	O	O	OTHERS	I
who	who	O	O	O	O
developed	developed	O	O	O	O
erythema	erythema	O	DISEASE	OTHERS	I
nodosum	nodosum	O	DISEASE	OTHERS	I
during	during	O	O	O	O
ATRA	atra	O	O	OTHERS	I
therapy	therapy	O	O	O	O
.	.	O	O	O	O

Fever	fever	O	DISEASE	OTHERS	I
and	and	O	O	O	O
subsequent	subsequent	O	O	O	O
multiple	multiple	O	O	O	O
painful	painful	O	O	OTHERS	I
erythematous	erythematous	O	O	OTHERS	I
nodules	nodules	O	O	OTHERS	I
over	over	O	O	O	O
extremities	extremities	O	O	O	O
developed	developed	O	O	O	O
on	on	O	O	O	O
D11	d11	O	O	O	O
,	,	O	O	O	O
D16	d16	O	O	O	O
,	,	O	O	O	O
D17	d17	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
D19	d19	O	O	O	O
,	,	O	O	O	O
respectively	respectively	O	O	O	O
,	,	O	O	O	O
after	after	O	O	O	O
ATRA	atra	O	O	OTHERS	I
therapy	therapy	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
skin	skin	O	O	O	O
biopsy	biopsy	O	O	O	O
taken	taken	O	O	O	O
from	from	O	O	O	O
each	each	O	O	O	O
patient	patient	O	O	O	O
was	was	O	O	O	O
consistent	consistent	O	O	O	O
with	with	O	O	O	O
erythema	erythema	O	DISEASE	OTHERS	I
nodosum	nodosum	O	DISEASE	OTHERS	I
.	.	O	O	O	O

All	all	O	O	O	O
patients	patients	O	O	O	O
received	received	O	O	O	O
short	short	O	O	O	O
course	course	O	O	O	O
of	of	O	O	O	O
steroids	steroids	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Fever	fever	O	DISEASE	OTHERS	I
subsided	subsided	O	O	O	O
rapidly	rapidly	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
skin	skin	O	O	O	O
lesions	lesions	O	O	O	O
regressed	regressed	O	O	O	O
completely	completely	O	O	O	O
.	.	O	O	O	O

All	all	O	O	O	O
patients	patients	O	O	O	O
achieved	achieved	O	O	O	O
complete	complete	O	O	O	O
remission	remission	O	O	O	O
without	without	O	O	O	O
withdrawal	withdrawal	O	O	O	O
of	of	O	O	O	O
ATRA	atra	O	O	OTHERS	I
.	.	O	O	O	O

ATRA	atra	O	O	OTHERS	I
seemed	seemed	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
the	the	O	O	O	O
most	most	O	O	O	O
possible	possible	O	O	O	O
etiology	etiology	O	O	O	O
of	of	O	O	O	O
erythema	erythema	O	DISEASE	OTHERS	I
nodosum	nodosum	O	DISEASE	OTHERS	I
in	in	O	O	O	O
our	our	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

Short-term	short-term	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
steroid	steroid	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
very	very	O	O	O	O
effective	effective	O	O	O	O
in	in	O	O	O	O
ATRA-induced	atra-induced	O	O	O	O
erythema	erythema	O	DISEASE	OTHERS	I
nodosum	nodosum	O	DISEASE	OTHERS	I
.	.	O	O	O	O

